Hydrogen sulfide-induced hypometabolism prevents renal ischemia/reperfusion injury
- PMID: 19628669
- PMCID: PMC2736772
- DOI: 10.1681/ASN.2008121269
Hydrogen sulfide-induced hypometabolism prevents renal ischemia/reperfusion injury
Abstract
Hydrogen sulfide (H(2)S) can induce a hypometabolic, hibernation-like state in mammals when given in subtoxic concentrations. Pharmacologically reducing the demand for oxygen is a promising strategy to minimize unavoidable hypoxia-induced injury such as ischemia/reperfusion injury during renal transplantation. Here we show that H(2)S reduces metabolism in vivo, ex vivo, and in vitro. Furthermore, we demonstrate the beneficial effects of H(2)S-induced hypometabolism in a model of bilateral renal ischemia/reperfusion injury using three different treatment strategies. The results demonstrate striking protective effects on survival, renal function, apoptosis, and inflammation. A hypometabolic state induced by H(2)S might have therapeutic potential to protect kidneys that suffer from hypoxia.
Figures


Similar articles
-
Effects of intravenous sulfide during porcine aortic occlusion-induced kidney ischemia/reperfusion injury.Shock. 2011 Feb;35(2):156-63. doi: 10.1097/SHK.0b013e3181f0dc91. Shock. 2011. PMID: 20661185
-
Hydrogen Sulfide Treatment Mitigates Renal Allograft Ischemia-Reperfusion Injury during Cold Storage and Improves Early Transplant Kidney Function and Survival Following Allogeneic Renal Transplantation.J Urol. 2015 Dec;194(6):1806-15. doi: 10.1016/j.juro.2015.07.096. Epub 2015 Aug 1. J Urol. 2015. PMID: 26239336
-
Beneficial effects of gaseous hydrogen sulfide in hepatic ischemia/reperfusion injury.Transpl Int. 2012 Aug;25(8):897-908. doi: 10.1111/j.1432-2277.2012.01514.x. Epub 2012 Jun 21. Transpl Int. 2012. PMID: 22716165
-
Potential applications of hydrogen sulfide-induced suspended animation.Curr Med Chem. 2009;16(10):1295-303. doi: 10.2174/092986709787846631. Curr Med Chem. 2009. PMID: 19355886 Review.
-
Hydrogen sulfide and renal ischemia.Expert Rev Clin Pharmacol. 2011 Jan;4(1):49-61. doi: 10.1586/ecp.10.127. Expert Rev Clin Pharmacol. 2011. PMID: 22115348 Review.
Cited by
-
Sodium hydrosulfide prevents hypertension and increases in vascular endothelial growth factor and soluble fms-like tyrosine kinase-1 in hypertensive pregnant rats.Naunyn Schmiedebergs Arch Pharmacol. 2016 Dec;389(12):1325-1332. doi: 10.1007/s00210-016-1296-5. Epub 2016 Sep 12. Naunyn Schmiedebergs Arch Pharmacol. 2016. PMID: 27620880
-
Protective effect of H2S on LPS‑induced AKI by promoting autophagy.Mol Med Rep. 2022 Mar;25(3):96. doi: 10.3892/mmr.2022.12612. Epub 2022 Jan 21. Mol Med Rep. 2022. PMID: 35059738 Free PMC article.
-
H2S during circulatory shock: some unresolved questions.Nitric Oxide. 2014 Sep 15;41:48-61. doi: 10.1016/j.niox.2014.03.163. Epub 2014 Mar 18. Nitric Oxide. 2014. PMID: 24650697 Free PMC article. Review.
-
Is pharmacological, H₂S-induced 'suspended animation' feasible in the ICU?Crit Care. 2014 Mar 18;18(2):215. doi: 10.1186/cc13782. Crit Care. 2014. PMID: 25028804 Free PMC article. Review. No abstract available.
-
Roles of Hydrogen Sulfide Donors in Common Kidney Diseases.Front Pharmacol. 2020 Nov 19;11:564281. doi: 10.3389/fphar.2020.564281. eCollection 2020. Front Pharmacol. 2020. PMID: 33364941 Free PMC article. Review.
References
-
- Reiffenstein RJ, Hulbert WC, Roth SH:Toxicology of hydrogen sulfide. Annu Rev Pharmacol Toxicol 32: 109–134, 1992 - PubMed
-
- Blackstone E, Morrison M, Roth MB:H2S induces a suspended animation-like state in mice. Science 308: 518, 2005 - PubMed
-
- Szabo C:Hydrogen sulphide and its therapeutic potential. Nat Rev Drug Discov 6: 917–935, 2007 - PubMed
-
- Blackstone E, Roth MB:Suspended animation-like state protects mice from lethal hypoxia. Shock 27: 370–372, 2007 - PubMed
-
- Elrod JW, Calvert JW, Morrison J, Doeller JE, Kraus DW, Tao L, Jiao X, Scalia R, Kiss L, Szabo C, Kimura H, Chow CW, Lefer DJ:Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function. Proc Natl Acad Sci U S A 104: 15,560–15,565, 2007 - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical